Franck LS, Boyce WT, Gregory GA, Jemerin J, Levine J, Miaskowski C. 2000. Plasma norepinephrine levels, vagal tone index, and flexor reflex threshold in premature neonates receiving intravenous morphine during the postoperative period: A pilot study. Clinical Journal of Pain 16(2):95-104.

Fraser AM, Brockert JE, Ward RH. 1995. Association of young maternal age with adverse reproductive outcomes. New England Journal of Medicine 332(17):1113-1117.

French JI, McGregor JA, Draper D, Parker R, McFee J. 1999. Gestational bleeding, bacterial vaginosis, and common reproductive tract infections: Risk for preterm birth and benefit of treatment. Obstetrics and Gynecology 93(5):715-724.

Fuentes-Afflick E, Hessol NA. 2000. Interpregnancy interval and the risk of premature infants. Obstetrics and Gynecology 95:383-390.

Fujimoto T, Parry S, Urbanek M, Sammel M, Macones G, Kuivaniemi H, Romero R, Strauss III JF. 2002. A single nucleotide polymorphism in the matrix metalloproteinase-1 (MMP-1) promoter influences amnion cell MMP-1 expression and risk for preterm premature rupture of the fetal membranes. Journal of Biological Chemistry 277(8):6296-6302.

Gabbard SA, Schryer J. 2003. Early amplification options. Mental Retardation and Developmental Disabilities Research Reviews 9(4):236-242.

Gaebler CP, Hanzlik JR. 1996. The effects of a prefeeding stimulation program on preterm infants. American Journal of Occupational Therapy 50(3):184-192.

Gagliardi L, Cavazza A, Brunelli A, Battaglioli M, Merazzi D, Tandoi F, Cella D, Perotti GF, Pelti M, Stucchi I, Frisone F, Avanzini A, Bell R. 2004. Assessing mortality risk in very low birthweight infants: A comparison of CRIB, CRIB-II, and SNAPPE-II. Archives of Disease in Childhood: Fetal and Neonatal Edition 89(5):F419-F422.

Gamsu HR, Mullinger BM, Donnai P, Dash CH. 1989. Antenatal administration of betamethasone to prevent respiratory distress syndrome in preterm infants: Report of a UK multicentre trial. British Journal of Obstetrics and Gynaecology 96(4):401-410.

Gan XD, Back SD, Rosenberg PA, Volpe JJ. 1997. Stage-specific vulnerability of rat oligodendrocytes in culture to non-NMDA receptor-mediated toxicity. Social Neuroscience 2(Abstr):17420.

Gappa M, Berner MM, Hohenschild S, Dammann CEL, Bartmann P. 1999. Pulmonary function at school-age in surfactant-treated preterm infants. Pediatric Pulmonology 27(3): 191-198.

Gardosi JO. 2005. Prematurity and fetal growth restriction. Early Human Development 81(1):43-49.

Gardosi J, Kady SM, McGeown P, Francis A, Tonks A, Ben-Tovim D, Phillips PA, Crotty M. 2005. Classification of stillbirth by relevant condition at death (ReCoDe): Population based cohort study. British Medical Journal 331(7525):1113-1117.

Garfield RE. 1988. Structural and functional studies of the control of myometrial contractility and labour. In: McNellis D, Challis JRG, MacDonald PC, Nathanielsz PW, Roberts JM eds. The Onset of Labour: Cellular and Integrative Mechanisms. Ithaca, NY: Perinatology Press. Pp. 55-80.

Garfield RE, Gasc JM, Baulieu EE. 1987. Effects of the antiprogesterone RU 486 on preterm birth in the rat. American Journal of Obstetrics and Gynecology 157(5):1281-1285.

Garite TJ, Clark R, Thorp JA. 2004. Intrauterine growth restriction increases morbidity and mortality among premature neonates. American Journal of Obstetrics and Gynecology 191(2):481-487.

Gariti DL, Zollinger TW, Look KY. 2005. Factors detracting students from applying for an obstetrics and gynecology residency. American Journal of Obstetrics and Gynecology 193:289-293.

Gatts JD, Wallace DH, Glasscock GF, McKee E, Cohen RS. 1994. A modified newborn intensive care unit environment may shorten hospital stay. Journal of Perinatology: Official Journal of the California Perinatal Association 14(5):422-427.

Front Matter (R1-R18)

Summary (1-30)

1 Introduction (31-52)

SECTION I Measurement : 2 Measurement of Fetal and Infant Maturity (53-83)

Section I Recommendations (84-86)

SECTION II Causes of Preterm Birth: 3 Behavioral and Psychosocial Contributors to Preterm Birth (87-123)

4 Sociodemographic and Community Factors Contributing to Preterm Birth (124-147)

5 Medical and Pregnancy Conditions Associated with Preterm Birth (148-168)

6 Biological Pathways Leading to Preterm Birth (169-206)

7 Role of Gene-Environment Interactions in Preterm Birth (207-228)

8 Role of Environmental Toxicants in Preterm Birth (229-254)

Section II Recommendations (255-258)

SECTION III Diagnosis and Treatment of Preterm Labor: 9 Diagnosis and Treatment of Conditions Leading to Spontaneous Preterm Birth (259-307)

Section III Recommendations (308-310)

SECTION IV Consequences of Preterm Birth: 10 Mortality and Acute Complications in Preterm Infants (311-345)

11 Neurodevelopmental, Health, and Family Outcomes for Infants Born Preterm (346-397)

12 Societal Costs of Preterm Birth (398-429)

Section IV Recommendations (430-432)

SECTION V Research and Policy: 13 Barriers to Clinical Research on Preterm Birth and Outcomes of Preterm Infants (433-454)

14 Public Policies Affected by Preterm Birth (455-472)

Section V Recommendations (473-476)

15 A Research Agenda to Investigate Preterm Birth (477-492)

References (493-590)

Appendix A Data Sources and Methods (591-603)

Appendix B Prematurity at Birth: Determinents, Consequences, and Geographic Variation (604-643)

Appendix C A Review of Ethical Issues involved in Premature Birth (644-687)

Appendix D A Systematic Review of Costs Associated with Preterm Birth (688-724)

Appendix E Selected Programs Funding Preterm Birth Research (725-731)

Appendix F Committee and Staff Biographies (732-740)

Index (741-772)